Skip to main content

Find Clinical Trials

Home
Conditions
Dyslipidemia

Clinical trial condition

Dyslipidemia

Explore clinical trials studying Dyslipidemia. Study availability and eligibility vary by location and protocol.

389 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemia trial results

Completed

Obese Patients With Untreated Dyslipidemias

NCT00029835

Conditions: Body Weight, Dyslipidemia, Dyslipidemias, +9 more
Locations: Clinic of Physicians and Surgeons, LTD Mesa, Arizona, United States

Arizona Clinical Research Center, Inc. Tucson, Arizona, United States

Irvine Center for Clinical Research (ICCR) Irvine, California, United States

Los Angeles Clinical Trials Los Angeles, California, United States

View all 35 locations

View Trial Details

Completed

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients

NCT00239967

Conditions: Body Weight, Dyslipidemia, Dyslipidemias, +9 more
Locations: Sanofi-aventis Administrative Office Bridgewater, New Jersey, United States

Sanofi-aventis Administrative Office Macquarie Park, Australia

Sanofi-aventis Administrative Office São Paulo, Brazil

Sanofi-aventis Administrative Office Laval, Canada

View all 14 locations

View Trial Details

Completed

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

NCT00240305

Conditions: Dyslipidemia, Dyslipidemias, Glucose Metabolism Disorders, +6 more
Locations: Research Site Perth, Western Australia, Australia

View Trial Details

Completed

Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period

NCT00845637

Conditions: Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations: Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil

View Trial Details

Completed

Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests

NCT00108212

Conditions: Dyslipidemia, Dyslipidemias, Inflammation, +5 more
Locations: VA Maryland Health Care System Baltimore, Maryland, United States

View Trial Details

Completed

Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia

NCT00345410

Conditions: Body Weight, Dyslipidemia, Dyslipidemias, +9 more
Locations: Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States

View Trial Details

Completed

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin

NCT00593047

Conditions: Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
Locations: Carl-Peter Anderberg Gothemburg, Sweden

View Trial Details

Completed

SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia

NCT00194402

Conditions: Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
Locations: Northwest Lipid Research Clinic, University of Washington Seattle, Washington, United States

View Trial Details

Completed

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

NCT00689442

Conditions: Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations: Amsterdam, Netherlands

View Trial Details

Completed

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

NCT00688558

Conditions: Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations: Amsterdam, Netherlands

View Trial Details